Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Microneedle Stamp for Peanut Allergy Moves Through First Human Trial

100% of Pediatric Patients with OFC Induced Anaphylaxis Responded to Single...

Nanoparticle Prevented Anaphylaxis Without Side Effects in Mouse Study

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Update On Neffy, the Epinephrine Nasal Spray from ARS Pharma

Gut Bacteria and Metabolite Can Help Prevent Food Allergies and Other...

FDA Grants Xolair Priority Review for Children and Adults with...

Study Shows Bryn’s Epinephrine Nasal Spray Absorbed as Fast and Lasted...

FDA Fast Tracks Alladapt’s ADP101 for the Treatment of Single and...

DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler...

Alladapt’s Multi-Allergen OIT Candidate Shows Promise in Clinical Study

Follow Us

Your School On Our Map

Put Your School on the Map